Medical cannabis startup Tilray raises $60 mln in Series A round

Tilray, a Canadian medical cannabis startup, has raised $60 million in a Series A financing. The company, owned and funded since its founding in 2014 by U.S. cannabis private equity firm Privateer Holdings, was backed in the Series A for the first time by unidentified institutional investors. Tilray researches, cultivates, processes and distributes medical cannabis and cannabinoids. Headquartered in Nanaimo, British Columbia and led by CEO Brendan Kennedy, the company will use the funds raised to increase production capacity in North America and Europe, and scale distribution of products to more patients and pharmacies around the globe.


Tilray® Announces Completion of Series A Funding Round Led by Global Institutional Investors

C$60 million Series A financing will enable Tilray to increase production capacity and expand distribution in North America and Europe

TORONTO – Tilray, a global pioneer in medical cannabis research, cultivation, processing and distribution, today announced the completion of its Series A funding round totaling C$60

... read more at: